Treatment Registry
TR-0147 ActiveRecorded September 2, 2026

Brand tirzepatide

Sold by beyondMD · every brand tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$129

Medication · Zepbound® Consultation Program$129

Added from the figures recorded below.

Price

TermPer monthCharged today
Zepbound® Consultation Program

Zepbound® Consultation Program Zepbound® is an FDA-approved prescription medication for chronic weight management in adults who mee... Starting at $129

source

Per month$129Charged today$129
Visit beyondMD

We earn nothing from this link. beyondMD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesNot disclosed as of September 3, 2026
Cancellation“Once a prescription has been transmitted to a pharmacy and the pharmacy has begun processing, preparing, compounding, or dispensing the medication, the medication order generally cannot be canceled, returned, or refunded.”

Not yet checked: pharmacy, prescriber, membership and consult fee.

Recorded from beyondmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0147
Readings
1

Related records

What else beyondMD sells

All beyondMD programs and terms

Brand tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 59 records of the same molecule.

Cite this entry

Treatment Registry. (2026). beyondMD brand tirzepatide (TR-0147). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0147

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.